Mefenamic acid 50mg/5ml oral suspension
BNF presentation 1001010N0AAABAB within chapter Musculoskeletal and Joint Diseases. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Presentation code
1001010N0AAABAB
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
95
NHS spend (£)
£42,885.04
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 11 |
| February 2025 | 1 |
| December 2024 | 1 |
| November 2024 | 15 |
| October 2024 | 11 |
| July 2024 | 15 |
| May 2024 | 3 |
| July 2021 | 4 |
| June 2021 | 4 |
| December 2020 | 14 |
| November 2020 | 16 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 4 | No data available |
|
Stanmore Medical Group
ODS E82005
|
3 | 06K - HERTFORDSHIRE AND WEST ESSEX ICB |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |